Open-label randomized comparative study of ceftriaxone vs. ampicillin/sulbactam in adults with mild to moderate community-acquired pneumonia

INTERVENTION: Ceftriaxone 2g IV, every 24 hrs, for 4‐14 days. Clarithromycin 200mg PO, bid, for 4‐14 days. May be adjusted when renal failure. Ampicillin/sulbactam 3g IV, every 12 hrs, for 4‐14 days. Clarithromycin 200mg PO, bid, for 4‐14 days. May be adjusted when renal failure. CONDITION: Community‐acquired pneumonia PRIMARY OUTCOME: Clinical response at the end of therapy, days 11‐14 SECONDARY OUTCOME: Early clinical response at days 4 and 7 ; Bacteriological response at days 11‐14 (in bacteriologically evaluable patients) ; Survival at day 30 INCLUSION CRITERIA: